doi: 10.1016/j.physbeh.2015.01.024 127 KeskitaloKTuorilaHSpectorTDCherkasLFKnaapilaAKaprioJet al
AARP Hearing Center A new kind of prescription drug is dramatically changing the treatment of Type 2 diabetes and obesity, yet a new AARP survey finds many Americans are not familiar with it
Whey Protein: Whey protein, like Lean XP, helps increase your protein intake, reduce hunger by making you feel fuller and boost your metabolism

The AMPK complex regulates the activity of numerous transcription factors involved in lipid metabolism, inflammation, autophagy, and gluconeogenesis.36 At the level of the liver, gluconeogenesis is reduced due to mitochondrial complex 1 inhibition, generating an increase in potential cell reduction (NADH: NAD), as well as in mitochondrial complex IV due to the inhibition dependent on glycerol-3-phosphate dehydrogenase (mGPHD ).37 In brown fatty tissue, this biguanide reduces the proinflammatory status conditioned by M1 macrophages through hypoxia-inducible factor 1 alpha (HIF-1 alpha), restoring the beta-adrenergic response.38 In the digestive tract, it induces a transitory inhibition of glucose absorption and abundance of the sodium-glucose transporter 1 (SGLT1) in the apical membrane of the jejunal enterocytes.37 Acarbose Acarbose is an alpha-glucosidase inhibitor, a group of medications that makes up part of the oral antidiabetics that act through the competitive and reversible inhibition of intestinal alpha-glucosidase.39 Alpha-glucosidase is an intestinal enzyme that favors glucose absorption through the enzymatic degradation of polysaccharides and disaccharides into said monosaccharide

Analyzing data for the 80 percent of participants not taking a GLP-1 allowed the researchers to factor in diabetes severity
The American Journal of Managed Care